Literature DB >> 8913279

Tumor-associated antigen 90K activates myelomonocytic cell line THP-1.

Z Z Altindag1, C Marth, G Werner-Felmayer, C Natoli, A G Zeimet, H Wachter, S Iacobelli, D Fuchs.   

Abstract

90K is a tumor-associated antigen. Using myelomonocytic cell line THP-1 we determined neopterin production and tryptophan degradation after exposure of cells to 90K in the presence and the absence of interferon-gamma. Interferon-gamma is a well known stimulus for THP-1 cells inducing e.g. neopterin production and tryptophan degradation. Treatment of cells with 50 micrograms/ml 90K induced significant neopterin formation, and the exposure of cells to 90K in addition to 100 U/ml interferon-gamma amplified neopterin production compared to the sole effect of interferon-gamma. In parallel, a significant degradation of tryptophan was observed in culture supernatants leading to the formation of kynurenine. When the cells were treated with the combination of 90K and interferon-gamma the degradation of tryptophan was further enhanced. The data demonstrate that tumor-associated antigen 90K interferes with immunocompetent target cells and is able to induce a biochemical response in monocytic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913279     DOI: 10.1016/0304-3835(96)04364-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura.

Authors:  P Pelliccia; C Natoli; M T Petitti; A Verrotti; F Chiarelli; S Iacobelli
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  Elevated plasma levels of 90K (Mac-2 BP) immunostimulatory glycoprotein in HIV-1-infected children.

Authors:  B Gröschel; J J Braner; M Funk; R Linde; H W Doerr; J Cinatl; S Iacobelli
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  Human milk 90K (Mac-2 BP): possible protective effects against acute respiratory infections.

Authors:  B Fornarini; S Iacobelli; N Tinari; C Natoli; M De Martino; G Sabatino
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.

Authors:  Heinz Läubli; Frederico Alisson-Silva; Michal A Stanczak; Shoib S Siddiqui; Liwen Deng; Andrea Verhagen; Nissi Varki; Ajit Varki
Journal:  J Biol Chem       Date:  2014-10-15       Impact factor: 5.157

5.  Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex.

Authors:  Gang Xu; Zhangchuan Xia; Feiyan Deng; Lin Liu; Qiming Wang; Yi Yu; Fubing Wang; Chengliang Zhu; Weiyong Liu; Zhikui Cheng; Ying Zhu; Li Zhou; Yi Zhang; Mengji Lu; Shi Liu
Journal:  PLoS Pathog       Date:  2019-08-12       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.